Continuous Glucose Monitoring Systems Market

Continuous Glucose Monitoring Systems Market Size by Component (Sensors, Transmitters, Receivers, and Insulin Pumps), Demography (Child Population and Adult Population), Application (Type-1 Diabetes, Type-2 Diabetes and Gestational Diabetes), End User (Home Healthcare, Hospitals and Others), Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2023 to 2032

Base Year: 2022 Historical Data: 2019-21
  • Report ID: TBI-13405
  • Published Date: Apr, 2023
  • Pages: 237
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global continuous glucose monitoring systems market is anticipated to reach USD 26,023.61 million by 2032, at a CAGR of 12.64% from 2023 to 2032. The surging incidence of diabetes and the growing acceptance of continuous glucose monitoring (CGM) systems drive the market's growth. Further, the growing elderly population, increasing demand for diagnostics, and unsatisfied healthcare needs are expected to drive the market share of the continuous glucose monitoring (CGM) systems market. Research and developments in the medical device industry for creating innovative continuous glucose monitoring systems will create positive scope for the continuous glucose monitoring (CGM) systems market in the upcoming period.

Market Introduction:

The continuous glucose monitoring (CGM) system is a medical device that measures and tracks blood sugar levels in real-time. People with type 2 diabetes and type 1 diabetes mainly use CGM systems to control their blood sugar and improve health and quality of life. These systems typically include a tiny sensor implanted beneath the skin to read glucose levels every few minutes, a transmitter that sends the data to a display device, and a monitor that interprets the data. Continuous glucose monitoring systems (CGMs) treat people with diabetes and other conditions to control their blood sugar levels and adjust their insulin or medications accordingly. These systems can also identify patterns in glucose levels and warn patients of potential problems early on.

Continuous Glucose Monitoring Systems Market Size

Get an overview of this study by requesting a free sample

Recent Development

May 2022 - The U.S. Food and Drug Administration (FDA) has approved Abbott's FreeStyle Libre 3 system for continuous glucose monitoring in children. This will help Abbott to make a strong position in the continuous glucose monitoring system market.

June 2022 - Senseonics Inc., one of the leaders in implantable continuous glucose monitoring systems, has earned a CE Mark license for its innovative new continuous glucose monitoring system Eversense E3  in Europe. Eversense E3 is designed to continuously measure blood glucose levels for six months in diabetic patients 18 and older.

September 2022 - Medical technology company GlucoRx and UK-based Cardiff University have developed a non-invasive, multi-sensor continuous blood glucose monitoring (CGM) system. The system uses radio frequency technology and a multi-sensory approach to measure blood glucose levels exactly and non-invasively minute by minute.

December 2022 - The USA Food and Drug Administration (FDA) has approved Dexcom's continuous glucose monitoring system G7. Dexcom G7 is one of the exact & correct integrated glucose monitoring systems (iCGM). The approval will help Dexcom position firmly in the continuous glucose monitoring system market.

Market Dynamics:

Drivers

Increasing Diabetes Prevalence – There are several main reasons for the high prevalence of diabetes, including growing urbanization and sedentary lifestyles in both emerging and developed countries. There is also a significant increase in the majority of insulin-dependent type 1 and type 2 diabetes, which is the main reason behind the frequent acceptance of these continuous glucose monitoring systems worldwide. Additionally, there is an increasing need for diabetes monitoring systems/devices such as CGMs owing to many insulin-dependent diabetic patients, favourable refund policies and new innovative product launches by market players.

Real-Time Monitoring for 24*7 - Real-time monitoring (24*7) of insulin-dependent patients or patients with type 2 diabetes is now feasible due to the adoption of cutting-edge technologies such as continuous glucose monitoring systems. Moreover, continuous glucose monitoring (CGM) systems offer several advantages over SMBG (self-monitoring blood glucose) systems, including convenience, less intrusive, offer fast & correct data, and at the same time real-time monitoring. Therefore, these different benefits have played an essential role in changing the perception of CGM by patients and healthcare professionals.

Restraints:

High Cost - The rising cost of continuous glucose monitoring systems/devices is one of the primary causes hampering the surge of the global continuous glucose monitoring (CGM) systems market. Continuous glucose monitoring systems are more costly than standard blood glucose meters, as the highly advanced lifetime sensor is a primary factor affecting user acceptability, price, and inconvenience. Additionally, governments, insurance companies, and health plans in various countries do not reimburse CGM; thus, patients hesitate to accept CGM, limiting the market's growth.

Opportunities:

Rising Government Support and R&D - Moreover, the medical industry in emerging countries is growing exponentially due to the increasing government investments in improving healthcare infrastructure, the growing need for improved healthcare services, and advances in research and development for healthcare activities in emerging economies.

Routine Inspection of Blood Glucose Levels - The continuous glucose monitoring (CGM) systems market is expected to experience a higher CAGR over the forecast period because it can monitor patients' glucose levels regularly. The growing reputation of continuous glucose monitoring (CGM) systems in both developed and developing countries has led to a massive growth of this market and the application of this cutting-edge technology in various industry sections. For example, a report published (2021) by Wiley concluded that continuous glucose monitoring systems are more valuable than self-monitored blood glucose in controlling and managing diabetes due to their minimally invasive process, ease of use and rapid results.

Challenges:

Lower Diagnosis Rate of Diabetes & Treatment - A large proportion of the population with undiagnosed diabetes is one of the main reasons for the low adoption of continuous glucose monitoring systems, especially in emerging countries. Countries such as Brazil, India, South Africa, China, and others have higher rates of delay in testing and diagnosis than wealthier countries owing to general ignorance about chronic diseases such as diabetes. Moreover, the market's growth is hindered by the need for more modern advanced procedures in public or private institutions and limited access to advanced healthcare infrastructure.

Regional segmentation analysis:

The regions analyzed for the market include North America, South America, Europe, Asia Pacific, and the Middle East & Africa.

North America generated the highest market share in 2022 and is projected to witness a prominent rise over the forecast period because of the rising prevalence of diabetes and increasing awareness of continuous glucose monitoring systems among users such as diabetics. South America is projected to witness a steady boost over the forecast period due to the increasing awareness of CGM systems among diabetic patients in the region.

Europe is expected to rise at a profitable rate from 2023 to 2032 due to the increasing older population, increasing rate of type 2 diabetes, rising activity in investments in research and development, and increased need for glucose monitors in healthcare settings.

The Asia-Pacific region is projected to achieve the highest growth rate due to the growing population base of elderly diabetics and increasing government expenditure to deliver better quality healthcare services in different regions, including developing regions such as China and India. The Middle East and Africa (MEA) market is projected to rise at a modest percentage over the forecast period due to the growing number of diabetes mellitus, limited knowledge of continuous diabetes monitoring systems and narrow access to advanced systems/devices among people.

North America Region Continuous Glucose Monitoring Systems Market Share in 2022 - 39.61%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Component Segment Analysis

The component section is divided into sensors, transmitters, receivers and insulin pumps. The sensors segment achieved the largest market share in 2022. Technological developments to enhance the efficiency of these sensors are projected to boost the surge of the segment over the forecast period (2023-2032). The sensor, the most complex part of a continuous glucose monitor system, is made of a wire (metallic filament) slimmer than a sewing needle inserted into the layer of fat under the skin. The sensors' technology is marginally distinct from that used in transmitters and receivers. Glucose oxidase is used to reveal blood sugar levels. The receiver segment will likely rise at the highest rate over the forecast period. A receiver, also called a reader, is a smartphone app or device that presents real-time blood glucose details from a sensor. Some systems offer apps for viewing these details, while continuous glucose monitoring systems from Abbott and Dexcom offer individual small movable devices. These devices are beneficial for end users who do not have smartphones.

Demography Segment Analysis

The demography section includes the child population and adult population. In 2022, the continuous glucose monitoring (CGM) systems market was dominated by the adult demographic segment and this trend is expected to carry over the forecast period. This is due to the increasing majority of diabetes and a growing number of older people. A continuous glucose monitoring system is an ideal tool for controlling diabetes in adults because this is a 'turnkey' treatment that is highly effective in controlling & managing diabetes and is a very cost adequate system for working category/employees, which leads to its promotion as well as adoption by these people.

Application Segment Analysis

The application segment includes type-1 diabetes, type-2 diabetes, and gestational diabetes. The type 2 diabetes segment accounted for the highest market share of the continuous glucose monitoring (CGM) systems market in 2022 due to the majority of insulin-dependent type 2 diabetics. Furthermore, the continuous glucose monitoring system is anticipated to be operated frequently in the type 1 diabetes population owing to its clinically proven efficacy in reducing the risk of hypoglycemia in these people.

End User Segment Analysis

The end user section includes home healthcare, hospitals, and others. The home healthcare segment reported the highest market share in 2022 and is projected to gain the maximum CAGR over the forecast period from 2023-2032. The continuous glucose monitoring (CGM) system provides patients with low insulin doses and helps constantly monitor blood sugar levels. The home healthcare segment is anticipated to increase the need for continuous glucose monitoring systems due to the expertise and easy monitoring of blood glucose levels. In addition, the increased susceptibility of people with diabetes during COVID-19 and the demand for the accurate management of blood sugar levels has led to an increase in its acceptance among end users (patients). The hospital segment will register a good market share over the forecast period owing to the increasing hospital visits of diabetic patients and premature difficulties of diabetes such as neuropathy, retinopathy, and nephropathy that require quick medical visits and hospitalization.

Some of the Key Market Players:
  • Abbott Laboratories
  • Animas
  • A. Menarini Diagnostics S.r.l
  • AgaMatrix
  • Ascensia Diabetes Care
  • B Braun Melsungen AG
  • Biolinq
  • DexCom, Inc.
  • Echo Therapeutics, Inc.
  • F. Hoffman-La Roche Ltd.
  • GlySens Incorporated
  • GE Healthcare
  • GNC Holdings, LLC
  • GlySure
  • Insulet Corporation
  • Johnson & Johnson
  • LifeScan IP Holdings LLC
  • Medtronic plc
  • Medtrum Technologies, Inc.
  • Nemaura Medical Inc.
  • Novo Nordisk A/S
  • NXP Semiconductors
  • OrSense
  • One Drop (Sano)
  • Roche
  • Senseonics Holdings, Inc.
  • STMicroelectronics
  • Terumo Corporation
  • Tandem Diabetes Care
  • Ypsomed AG

Report Description: 

Attribute Description
Market Size Revenue (USD Million), Volume (K Units), Price (USD/Unit)
Market size value in 2022 USD 7,914.82 Million
Market size value in 2032 USD 26,023.61 Million
CAGR (2023 to 2032) 12.64%
Historical data 2019-2021
Base Year 2022
Forecast 2023-2032
Regional Segments The regions are segmented into North America, South America, Asia Pacific, Europe, and Middle East and Africa.
Segments Component, Demography, Application, and End User

Frequesntly Asked Questions

As per The Brainy Insights, the size of the continuous glucose monitoring systems market was valued at USD 7,914.82 million in 2022 to USD 26,023.61 million by 2032.

The global continuous glucose monitoring systems market is growing at a CAGR of 12.64% during the forecast period 2023-2032.

The North America region became the largest market for continuous glucose monitoring systems.

Increasing diabetes prevalence is influencing the market's growth.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Component
          4.3.2. Market Attractiveness Analysis by Demography
          4.3.3. Market Attractiveness Analysis by Application
          4.3.4. Market Attractiveness Analysis by End User
          4.3.5. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing diabetes prevalence
          5.2.2. Real-time monitoring for 24*7
    5.3. Restraints
          5.3.1. High cost
    5.4. Opportunities
          5.4.1. Rising government support and R&D
          5.4.2. Routine inspection of blood glucose levels
    5.5. Challenges
          5.5.1. Lower diagnosis rate of diabetes & treatment

6. Global Continuous Glucose Monitoring Systems Market Analysis and Forecast, By Component
    6.1. Segment Overview
    6.2. Sensors
    6.3. Transmitters
    6.4. Receivers
    6.5. Insulin Pumps

7. Global Continuous Glucose Monitoring Systems Market Analysis and Forecast, By Demography
    7.1. Segment Overview
    7.2. Child Population
    7.3. Adult Population

8. Global Continuous Glucose Monitoring Systems Market Analysis and Forecast, By Application
    8.1. Segment Overview
    8.2. Type-1 Diabetes
    8.3. Type-2 Diabetes
    8.4. Gestational Diabetes

9. Global Continuous Glucose Monitoring Systems Market Analysis and Forecast, By End User
    9.1. Segment Overview
    9.2. Home Healthcare
    9.3. Hospitals
    9.4. Others

10. Global Continuous Glucose Monitoring Systems Market Analysis and Forecast, By Regional Analysis
    10.1. Segment Overview
    10.2. North America
          10.2.1. U.S.
          10.2.2. Canada
          10.2.3. Mexico
    10.3. Europe
          10.3.1. Germany
          10.3.2. France
          10.3.3. U.K.
          10.3.4. Italy
          10.3.5. Spain
    10.4. Asia-Pacific
          10.4.1. Japan
          10.4.2. China
          10.4.3. India
    10.5. South America
          10.5.1. Brazil
    10.6. Middle East and Africa
          10.6.1. UAE
          10.6.2. South Africa

11. Global Continuous Glucose Monitoring Systems Market-Competitive Landscape
    11.1. Overview
    11.2. Market Share of Key Players in the Continuous Glucose Monitoring Systems Market
          11.2.1. Global Company Market Share
          11.2.2. North America Company Market Share
          11.2.3. Europe Company Market Share
          11.2.4. APAC Company Market Share
    11.3. Competitive Situations and Trends
          11.3.1. Product Launches and Developments
          11.3.2. Partnerships, Collaborations, and Agreements
          11.3.3. Mergers & Acquisitions
          11.3.4. Expansions

12. Company Profiles
    12.1. Abbott Laboratories
          12.1.1. Business Overview
          12.1.2. Company Snapshot
          12.1.3. Company Market Share Analysis
          12.1.4. Company Product Portfolio
          12.1.5. Recent Developments
          12.1.6. SWOT Analysis
    12.2. Animas
          12.2.1. Business Overview
          12.2.2. Company Snapshot
          12.2.3. Company Market Share Analysis
          12.2.4. Company Product Portfolio
          12.2.5. Recent Developments
          12.2.6. SWOT Analysis
    12.3. A. Menarini Diagnostics S.r.l
          12.3.1. Business Overview
          12.3.2. Company Snapshot
          12.3.3. Company Market Share Analysis
          12.3.4. Company Product Portfolio
          12.3.5. Recent Developments
          12.3.6. SWOT Analysis
    12.4. AgaMatrix
          12.4.1. Business Overview
          12.4.2. Company Snapshot
          12.4.3. Company Market Share Analysis
          12.4.4. Company Product Portfolio
          12.4.5. Recent Developments
          12.4.6. SWOT Analysis
    12.5. Ascensia Diabetes Care
          12.5.1. Business Overview
          12.5.2. Company Snapshot
          12.5.3. Company Market Share Analysis
          12.5.4. Company Product Portfolio
          12.5.5. Recent Developments
          12.5.6. SWOT Analysis
    12.6. B Braun Melsungen AG
          12.6.1. Business Overview
          12.6.2. Company Snapshot
          12.6.3. Company Market Share Analysis
          12.6.4. Company Product Portfolio
          12.6.5. Recent Developments
          12.6.6. SWOT Analysis
    12.7. Biolinq
          12.7.1. Business Overview
          12.7.2. Company Snapshot
          12.7.3. Company Market Share Analysis
          12.7.4. Company Product Portfolio
          12.7.5. Recent Developments
          12.7.6. SWOT Analysis
    12.8. DexCom, Inc.
          12.8.1. Business Overview
          12.8.2. Company Snapshot
          12.8.3. Company Market Share Analysis
          12.8.4. Company Product Portfolio
          12.8.5. Recent Developments
          12.8.6. SWOT Analysis
    12.9. Echo Therapeutics, Inc.
          12.9.1. Business Overview
          12.9.2. Company Snapshot
          12.9.3. Company Market Share Analysis
          12.9.4. Company Product Portfolio
          12.9.5. Recent Developments
          12.9.6. SWOT Analysis
    12.10. F. Hoffman-La Roche Ltd.
          12.10.1. Business Overview
          12.10.2. Company Snapshot
          12.10.3. Company Market Share Analysis
          12.10.4. Company Product Portfolio
          12.10.5. Recent Developments
          12.10.6. SWOT Analysis
    12.11. GlySens Incorporated
          12.11.1. Business Overview
          12.11.2. Company Snapshot
          12.11.3. Company Market Share Analysis
          12.11.4. Company Product Portfolio
          12.11.5. Recent Developments
          12.11.6. SWOT Analysis
    12.12. GE Healthcare
          12.12.1. Business Overview
          12.12.2. Company Snapshot
          12.12.3. Company Market Share Analysis
          12.12.4. Company Product Portfolio
          12.12.5. Recent Developments
          12.12.6. SWOT Analysis
    12.13. GNC Holdings, LLC
          12.13.1. Business Overview
          12.13.2. Company Snapshot
          12.13.3. Company Market Share Analysis
          12.13.4. Company Product Portfolio
          12.13.5. Recent Developments
          12.13.6. SWOT Analysis
    12.14. GlySure
          12.14.1. Business Overview
          12.14.2. Company Snapshot
          12.14.3. Company Market Share Analysis
          12.14.4. Company Product Portfolio
          12.14.5. Recent Developments
          12.14.6. SWOT Analysis
    12.15. Insulet Corporation
          12.15.1. Business Overview
          12.15.2. Company Snapshot
          12.15.3. Company Market Share Analysis
          12.15.4. Company Product Portfolio
          12.15.5. Recent Developments
          12.15.6. SWOT Analysis
    12.16. Johnson & Johnson
          12.16.1. Business Overview
          12.16.2. Company Snapshot
          12.16.3. Company Market Share Analysis
          12.16.4. Company Product Portfolio
          12.16.5. Recent Developments
          12.16.6. SWOT Analysis
    12.17. LifeScan IP Holdings LLC
          12.17.1. Business Overview
          12.17.2. Company Snapshot
          12.17.3. Company Market Share Analysis
          12.17.4. Company Product Portfolio
          12.17.5. Recent Developments
          12.17.6. SWOT Analysis
    12.18. Medtronic plc
          12.18.1. Business Overview
          12.18.2. Company Snapshot
          12.18.3. Company Market Share Analysis
          12.18.4. Company Product Portfolio
          12.18.5. Recent Developments
          12.18.6. SWOT Analysis
    12.19. Medtrum Technologies, Inc.
          12.19.1. Business Overview
          12.19.2. Company Snapshot
          12.19.3. Company Market Share Analysis
          12.19.4. Company Product Portfolio
          12.19.5. Recent Developments
          12.19.6. SWOT Analysis
    12.20. Nemaura Medical Inc.
          12.20.1. Business Overview
          12.20.2. Company Snapshot
          12.20.3. Company Market Share Analysis
          12.20.4. Company Product Portfolio
          12.20.5. Recent Developments
          12.20.6. SWOT Analysis
    12.21. Novo Nordisk A/S
          12.21.1. Business Overview
          12.21.2. Company Snapshot
          12.21.3. Company Market Share Analysis
          12.21.4. Company Product Portfolio
          12.21.5. Recent Developments
          12.21.6. SWOT Analysis
    12.22. NXP Semiconductors
          12.22.1. Business Overview
          12.22.2. Company Snapshot
          12.22.3. Company Market Share Analysis
          12.22.4. Company Product Portfolio
          12.22.5. Recent Developments
          12.22.6. SWOT Analysis
    12.23. OrSense
          12.23.1. Business Overview
          12.23.2. Company Snapshot
          12.23.3. Company Market Share Analysis
          12.23.4. Company Product Portfolio
          12.23.5. Recent Developments
          12.23.6. SWOT Analysis
    12.24. One Drop (Sano)
          12.24.1. Business Overview
          12.24.2. Company Snapshot
          12.24.3. Company Market Share Analysis
          12.24.4. Company Product Portfolio
          12.24.5. Recent Developments
          12.24.6. SWOT Analysis
    12.25. Roche
          12.25.1. Business Overview
          12.25.2. Company Snapshot
          12.25.3. Company Market Share Analysis
          12.25.4. Company Product Portfolio
          12.25.5. Recent Developments
          12.25.6. SWOT Analysis
    12.26. Senseonics Holdings, Inc.
          12.26.1. Business Overview
          12.26.2. Company Snapshot
          12.26.3. Company Market Share Analysis
          12.26.4. Company Product Portfolio
          12.26.5. Recent Developments
          12.26.6. SWOT Analysis
    12.27. STMicroelectronics
          12.27.1. Business Overview
          12.27.2. Company Snapshot
          12.27.3. Company Market Share Analysis
          12.27.4. Company Product Portfolio
          12.27.5. Recent Developments
          12.27.6. SWOT Analysis
    12.28. Terumo Corporation
          12.28.1. Business Overview
          12.28.2. Company Snapshot
          12.28.3. Company Market Share Analysis
          12.28.4. Company Product Portfolio
          12.28.5. Recent Developments
          12.28.6. SWOT Analysis
    12.29. Tandem Diabetes Care
          12.29.1. Business Overview
          12.29.2. Company Snapshot
          12.29.3. Company Market Share Analysis
          12.29.4. Company Product Portfolio
          12.29.5. Recent Developments
          12.29.6. SWOT Analysis
    12.30. Ypsomed AG
          12.30.1. Business Overview
          12.30.2. Company Snapshot
          12.30.3. Company Market Share Analysis
          12.30.4. Company Product Portfolio
          12.30.5. Recent Developments
          12.30.6. SWOT Analysis

List of Table

1. Global Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

2. Global Sensors Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

3. Global Transmitters Lights Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

4. Global Receivers Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

5. Global Insulin Pumps Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

6. Global Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

7. Global Child Population Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

8. Global Adult Population Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

9. Global Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

10. Global Type-1 Diabetes Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

11. Global Type-2 Diabetes Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

12. Global Gestational Diabetes Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

13. Global Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

14. Global Home Healthcare Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

15. Global Hospitals Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

16. Global Others Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

17. Global Continuous Glucose Monitoring Systems Market, By Region, 2019-2032 (USD Million) (K Units)

18. North America Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

19. North America Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

20. North America Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

21. North America Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

22. U.S. Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

23. U.S. Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

24. U.S. Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

25. U.S. Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

26. Canada Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

27. Canada Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

28. Canada Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

29. Canada Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

30. Mexico Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

31. Mexico Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

32. Mexico Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

33. Mexico Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

34. Europe Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

35. Europe Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

36. Europe Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

37. Europe Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

38. Germany Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

39. Germany Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

40. Germany Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

41. Germany Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

42. France Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

43. France Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

44. France Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

45. France Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

46. U.K. Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

47. U.K. Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

48. U.K. Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

49. U.K. Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

50. Italy Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

51. Italy Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

52. Italy Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

53. Italy Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

54. Spain Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

55. Spain Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

56. Spain Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

57. Spain Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

58. Asia Pacific Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

59. Asia Pacific Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

60. Asia Pacific Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

61. Asia Pacific Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

62. Japan Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

63. Japan Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

64. Japan Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

65. Japan Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

66. China Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

67. China Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

68. China Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

69. China Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

70. India Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

71. India Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

72. India Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

73. India Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

74. South America Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

75. South America Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

76. South America Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

77. South America Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

78. Brazil Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

79. Brazil Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

80. Brazil Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

81. Brazil Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

82. Middle East and Africa Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

83. Middle East and Africa Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

84. Middle East and Africa Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

85. Middle East and Africa Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

86. UAE Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

87. UAE Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

88. UAE Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

89. UAE Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

90. South Africa Continuous Glucose Monitoring Systems Market, By Component, 2019-2032 (USD Million) (K Units)

91. South Africa Continuous Glucose Monitoring Systems Market, By Demography, 2019-2032 (USD Million) (K Units)

92. South Africa Continuous Glucose Monitoring Systems Market, By Application, 2019-2032 (USD Million) (K Units)

93. South Africa Continuous Glucose Monitoring Systems Market, By End User, 2019-2032 (USD Million) (K Units)

List of Figures 

1. Global Continuous Glucose Monitoring Systems Market Segmentation

2. Continuous Glucose Monitoring Systems Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Continuous Glucose Monitoring Systems Market Attractiveness Analysis by Component

9. Global Continuous Glucose Monitoring Systems Market Attractiveness Analysis by Demography

10. Global Continuous Glucose Monitoring Systems Market Attractiveness Analysis by Application

11. Global Continuous Glucose Monitoring Systems Market Attractiveness Analysis by End User

12. Global Continuous Glucose Monitoring Systems Market Attractiveness Analysis by Region

13. Global Continuous Glucose Monitoring Systems Market: Dynamics

14. Global Continuous Glucose Monitoring Systems Market Share by Component (2023 & 2032)

15. Global Continuous Glucose Monitoring Systems Market Share by Demography (2023 & 2032)

16. Global Continuous Glucose Monitoring Systems Market Share by Application (2023 & 2032)

17. Global Continuous Glucose Monitoring Systems Market Share by End User (2023 & 2032)

18. Global Continuous Glucose Monitoring Systems Market Share by Regions (2023 & 2032)

19. Global Continuous Glucose Monitoring Systems Market Share by Company (2022)

This study forecasts revenue at global, regional, and country levels from 2019 to 2032. The Brainy Insights has segmented the global continuous glucose monitoring systems market based on below-mentioned segments:

Global Continuous Glucose Monitoring Systems Market by Component:

  • Sensors
  • Transmitters
  • Receivers
  • Insulin Pumps

Global Continuous Glucose Monitoring Systems Market by Demography:

  • Child Population
  • Adult Population

Global Continuous Glucose Monitoring Systems Market by Application:

  • Type-1 Diabetes
  • Type-2 Diabetes
  • Gestational Diabetes

Global Continuous Glucose Monitoring Systems Market by End User:

  • Home Healthcare
  • Hospitals
  • Others

Global Continuous Glucose Monitoring Systems Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date